Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering of 13,333,333 shares of common stock of ConforMis, Inc.
The common stock is listed on the NASDAQ Global Select Market under the symbol “CFMS.”
Cowen and Canaccord Genuity acted as Joint book-running managers and SunTrust Robinson Humphrey acted as Lead manager.
Based in Bedford, Massachusetts, ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient’s unique anatomy. ConforMIS offers a broad line of customized knee implants and pre-sterilized, single-use instruments delivered in a single package to the hospital.
The Davis Polk corporate team included partner Richard D. Truesdell Jr. (Picture), counsel Yasin Keshvargar and associate Yoojin L. Kim. The intellectual property and technology team included counsel Michelle Ontiveros Gross and associate Jason J. Bang. Counsel Marcie A. Goldstein provided FINRA advice. The tax team included partner Mario J. Verdolini.
Involved fees earner: Richard Truesdell – Davis Polk & Wardwell; Yasin Keshvargar – Davis Polk & Wardwell; Yoojin Kim – Davis Polk & Wardwell; Michelle Ontiveros Gross – Davis Polk & Wardwell; Jason Bang – Davis Polk & Wardwell; Marcie Goldstein – Davis Polk & Wardwell; Mario Verdolini – Davis Polk & Wardwell;
Law Firms: Davis Polk & Wardwell;